Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Vancampfort, D.
Probst, M.
Scheewe, T.
Knapen, J.
De Herdt, A.
and
De Hert, M.
2012.
The functional exercise capacity is correlated with global functioning in patients with schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 125,
Issue. 5,
p.
382.
Papanastasiou, Evangelos
2012.
Interventions for the metabolic syndrome in schizophrenia: a review.
Therapeutic Advances in Endocrinology and Metabolism,
Vol. 3,
Issue. 5,
p.
141.
Galletly, Cherrie A
Foley, Debra L
Waterreus, Anna
Watts, Gerald F
Castle, David J
McGrath, John J
Mackinnon, Andrew
and
Morgan, Vera A
2012.
Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis.
Australian & New Zealand Journal of Psychiatry,
Vol. 46,
Issue. 8,
p.
753.
Mitchell, Alex J.
2012.
Psychiatric aspects of chronic physical disease.
Medicine,
Vol. 40,
Issue. 12,
p.
662.
Morrato, Elaine H
2012.
An update on lipid profile screening in second-generation antipsychotic users in the USA.
Clinical Lipidology,
Vol. 7,
Issue. 5,
p.
509.
Mitchell, Alex J
2012.
Understanding disproportionately high cardiometabolic risk in Australians treated for psychosis.
Australian & New Zealand Journal of Psychiatry,
Vol. 46,
Issue. 10,
p.
919.
van Gool, Ronald
and
van Meijel, Berno
2012.
Mind the body!.
Nederlands Tijdschrift voor Evidence Based Practice,
Vol. 10,
Issue. 2,
p.
4.
Lahti, M.
Tiihonen, J.
Wildgust, H.
Beary, M.
Hodgson, R.
Kajantie, E.
Osmond, C.
Räikkönen, K.
and
Eriksson, J.
2012.
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia.
Psychological Medicine,
Vol. 42,
Issue. 11,
p.
2275.
De Hert, Marc
Detraux, Johan
van Winkel, Ruud
Yu, Weiping
and
Correll, Christoph U.
2012.
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
Nature Reviews Endocrinology,
Vol. 8,
Issue. 2,
p.
114.
Mitchell, Alex J.
Delaffon, Vijay
and
Lord, Oliver
2012.
Let's get physical: improving the medical care of people with severe mental illness.
Advances in Psychiatric Treatment,
Vol. 18,
Issue. 3,
p.
216.
Binford, Sandra Haas
Johnson, Monique D.
Kennedy, Robert S.
and
Leffler, Joy Bartnett
2012.
Clinician Education Improves Lipid Monitoring in Patients Taking Second-Generation Antipsychotic Agents, Nationally and Locally.
Health Outcomes Research in Medicine,
Vol. 3,
Issue. 3,
p.
e121.
Foley, Debra L.
Mackinnon, Andrew
Watts, Gerald F.
Shaw, Jonathan E.
Magliano, Dianna J.
Castle, David J.
McGrath, John J.
Waterreus, Anna
Morgan, Vera A.
Galletly, Cherrie A.
and
Vinciguerra, Manlio
2013.
Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender.
PLoS ONE,
Vol. 8,
Issue. 12,
p.
e82606.
Skelton, Mike
Thacker, Simon
Forbes-Haley, Andrew
Kumar, Mahendra
and
Holliday, Eleanor
2013.
Psychiatrists' access to electronic laboratory results.
The Psychiatrist,
Vol. 37,
Issue. 5,
p.
160.
Steylen, Pauline M. J.
van der Heijden, Frank M. M. A.
Kok, Hans D. H.
Sijben, No A. E. S.
and
Verhoeven, Willem M. A.
2013.
Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment.
International Journal of Psychiatry in Clinical Practice,
Vol. 17,
Issue. 2,
p.
125.
Guenette, Melanie D.
Hahn, Margaret
Cohn, Tony A.
Teo, Celine
and
Remington, Gary J.
2013.
Atypical antipsychotics and diabetic ketoacidosis: a review.
Psychopharmacology,
Vol. 226,
Issue. 1,
p.
1.
Papanastasiou, Evangelos
2013.
The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review.
Therapeutic Advances in Psychopharmacology,
Vol. 3,
Issue. 1,
p.
33.
Lang, Donna J.
Barr, Alasdair M.
and
Procyshyn, Ric M.
2013.
Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness.
Current Cardiovascular Risk Reports,
Vol. 7,
Issue. 4,
p.
283.
Eapen, Valsamma
Shiers, David
and
Curtis, Jackie
2013.
Bridging the gap from evidence to policy and practice: Reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication.
Australian & New Zealand Journal of Psychiatry,
Vol. 47,
Issue. 5,
p.
435.
Murphy, Andrea Lynn
Gardner, David Martin
Kisely, Steve
Cooke, Charmaine
Kutcher, Stanley Paul
and
Hughes, Jean
2013.
Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain.
ISRN Obesity,
Vol. 2013,
Issue. ,
p.
1.
Chwastiak, Lydia
Cruza-Guet, Maria-Cristina
Carroll-Scott, Amy
Sernyak, Michael
and
Ickovics, Jeannette
2013.
Preventive Counseling for Chronic Disease: Missed Opportunities in a Community Mental Health Center.
Psychosomatics,
Vol. 54,
Issue. 4,
p.
328.